About | Free Trial

Last Update

2013-01-29T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Douglas Bakan?

Dr. Douglas Bakan A. PhD

Vice President, Product Development and Tech Services

Medicis Pharmaceutical Corporation

Direct Phone: (480) ***-****       

Email: d***@***.com

Medicis Pharmaceutical Corporation

7720 Dobson Road

Scottsdale, Arizona 85256

United States

Company Description

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. The Company is dedicated to helping patients attain a healthy and youthful appearance ... more

Find other employees at this company (562)

Background Information

Employment History

Vice President, Product Development

Medicis Pharmaceutical Corporation

Vice President, Product Development

Novalar Pharmaceuticals , Inc.

Vice President, Business Development

Alerion Biomedical Inc.

Chief Operating Officer

MetaProbe Inc

Vice President of Business Development At Alerion Biomedical

MetaProbe Inc

Facilities

MetaProbe Inc

Senior Director of Development

Neurocrine Biosciences , Inc.

Director of Pharmaceutical Formulations and Manufacturing

Corvas International , Inc.

Education

Ph.D.

bachelor of science degree
bioengineering

doctorate
biology

degrees

University of California , San Diego

Web References (12 Total References)


Novalar - Specialty Pharmaceuticals- Leadership Team

www.novalar.com [cached]

Doug Bakan, PhD Vice President, Product Development

Dr. Bakan joined Novalar in May 2008 as Vice President, Product Development. Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies. Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems. He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra™ line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC,; Director of Pharmaceutical Formulations and Manufacturing at Corvas International; and Associate Director of Product Development at Molecular Biosystems, Inc. Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging. Dr. Bakan earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work in the Department of Pharmacology at the University of Michigan.


Research Corporation Technologies | News

www.rctech.com [cached]

"We are pleased to have finalized this initial round of financing," said Douglas A. Bakan, MetaProbe chief operating officer.

...
Douglas A. Bakan, Ph.D., chief operating officer (858) 597-7528.


Novalar Management

www.novalarpharm.com [cached]

Doug BakanVice President, Product Development

Doug Bakan joined Novalar in May 2008 as Vice President, Product Development.Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies.Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems.He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC, a start-up company focused on developing biochemically activated imaging agents; Director of Pharmaceutical Formulations and Manufacturing at Corvas International, a company focused on developing drugs treating cardiovascular disease and cancer; and Associate Director of Product Development at Molecular Biosystems, Inc., where Albunex® and Optison®, the first cardiac ultrasound imaging agents, were developed and commercialized during his tenure.Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging.Doug earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work at the University of Michigan.


Doug BakanVice ...

www.novalar.com [cached]

Doug BakanVice President, Product Development

Doug Bakan joined Novalar in May 2008 as Vice President, Product Development.Dr. Bakan brings more than 20 years experience in the discovery, development, commercialization and licensing of novel pharmaceutical products and medical technologies.Immediately prior to joining Novalar, he served as Senior Director of Development at Neurocrine Biosciences where his team was responsible for program management of the company's diverse product pipeline aimed at treating diseases of the neurological and endocrine systems.He has also served as Vice President of Business Development at Alerion Biomedical, a company that developed and launched the Fenestra line of in vivo imaging agents for CT and microCT imaging; Chief Operating Officer at MetaProbe LLC, a start-up company focused on developing biochemically activated imaging agents; Director of Pharmaceutical Formulations and Manufacturing at Corvas International, a company focused on developing drugs treating cardiovascular disease and cancer; and Associate Director of Product Development at Molecular Biosystems, Inc., where Albunex® and Optison®, the first cardiac ultrasound imaging agents, were developed and commercialized during his tenure.Dr. Bakan is an author or co-author on more than 50 peer reviewed publications and abstracts, is an inventor on 5 issued and numerous pending patent applications, and has won several awards in the field of in vivo medical imaging.Doug earned his BS in bioengineering and his PhD in biochemistry and physiology from the University of California, San Diego and completed post-doctoral work at the University of Michigan.


CHI, Cambridge Healthtech Institute

www.chidb.com [cached]

Douglas A. Bakan, Ph.D., Alerion Biomedical, Inc.

Similar Profiles

Other People with this Name

Other people with the name Bakan

Syd Bakan
MindShare

Christine Bakan
Cisco Systems Inc

Murat Bakan
Schaeffler Technologies AG & Co

Paul Bakan
The DaVinci Group, LLC - USA

Danny Bakan
University of British ColumbiaKwantlen Polytechnic

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory